Data / Form D filings / Immunophotonics, Inc.
Immunophotonics, Inc.: Form D filings
Immunophotonics, Inc., a pharmaceuticals company in St. Louis, MO, filed 6 Form D notices with the SEC between 2010 and 2026. The latest, on September 4, 2026, reports $10.1 million sold of an offering with no set size to 45 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4340 Duncan Ave., Suite 212, St. Louis, MO, 63110
- Phone
- (314) 501-1919
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1490953
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | New notice | Indefinite | $10,147,612 | 45 | Jul 14, 2025 | sec.gov | |
| Mar 15, 2024 | New notice | $4,000,000 | $1,516,746 | $2,483,254 | 17 | Feb 29, 2024 | sec.gov |
| Feb 14, 2023 | New notice | $6,500,000 | $3,452,576 | $3,047,424 | 22 | Jan 6, 2023 | sec.gov |
| Jan 21, 2015 | New notice | $3,387,487 | $2,487,487 | $900,000 | 28 | Jun 12, 2014 | sec.gov |
| Jun 28, 2011 | New notice | $999,382 | $100,123 | $899,259 | 1 | Jun 14, 2011 | sec.gov |
| May 12, 2010 | New notice | $1,000,000 | $550,000 | $450,000 | 2 | Apr 27, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexander Michael Hurst | Executive Officer | |
| Robert H. Arch | Executive Officer | |
| Miguel M. Zubizarreta | Director | |
| Luciano Alleruzzo | Director, Promoter | |
| Jonathan Knowles | Director | |
| Wei Chen | Director, Promoter | |
| Jacqueline Hess | Director | |
| Richard Levenson | Director |
Every Form D from the week of Aug 31, 2026 · All recent filings in Missouri · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Immunophotonics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.